BlackRock Health Sciences Trust II
BMEZ · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $24 | $8 | -$26 | $60 |
| % Growth | 193.8% | 131.5% | -143.5% | – |
| Cost of Goods Sold | $0 | -$8 | $0 | $0 |
| Gross Profit | $24 | $29 | -$26 | $6 |
| % Margin | 100% | 352.4% | 100% | 10.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $6 |
| SG&A Expenses | $0 | $0 | $0 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$26 | $0 |
| Operating Expenses | $1 | $0 | -$26 | $6 |
| Operating Income | $1 | $8 | $2 | $0 |
| % Margin | 3.9% | 103.3% | -5.9% | 0.1% |
| Other Income/Exp. Net | $23 | $12 | -$28 | $0 |
| Pre-Tax Income | $23 | $20 | -$26 | $59 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $23 | $20 | -$26 | $59 |
| % Margin | 97.4% | 244.3% | 101.9% | 99.1% |
| EPS | 1.77 | 1.44 | -2.1 | -2.55 |
| % Growth | 22.9% | 168.6% | 17.6% | – |
| EPS Diluted | 1.77 | 1.44 | -2.1 | -2.55 |
| Weighted Avg Shares Out | 13 | 14 | 13 | 113 |
| Weighted Avg Shares Out Dil | 13 | 14 | 13 | 113 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$1 | -$2 | $0 | -$0 |
| EBITDA | $24 | $20 | -$26 | $59 |
| % Margin | 97.6% | 244.4% | 101.9% | 99.1% |